EP Patent

EP3808275A1 — Perfusion angiography combined with photoplethysmography imaging for peripheral vascular disease assessment

Assigned to Koninklijke Philips NV · Expires 2021-04-21 · 5y expired

What this patent protects

A device (13) and method for performing perfusion imaging receive image sequences that are acquired simultaneously by an X-ray imaging apparatus (2) and by a photoplethysmography imaging apparatus (3). When temporally aligned, changes in the perfusion states of a perfused organic…

USPTO Abstract

A device (13) and method for performing perfusion imaging receive image sequences that are acquired simultaneously by an X-ray imaging apparatus (2) and by a photoplethysmography imaging apparatus (3). When temporally aligned, changes in the perfusion states of a perfused organic tissue over time are extracted from the two image sequences and an image is generated for display on a display unit (5) which indicates the changes in the perfusion states at various locations of the perfused organ tissue, thereby capturing both deep organ tissue and superficial organ tissue perfusion properties. A diminution in an image signal strength in the photoplethysmography images caused by a passage of a bolus comprising a previously administered contrast agent (10) can be used to align the two concurrently acquired image sequences in time.

Drugs covered by this patent

Patent Metadata

Patent number
EP3808275A1
Jurisdiction
EP
Classification
Expires
2021-04-21
Drug substance claim
No
Drug product claim
No
Assignee
Koninklijke Philips NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.